Pluvicto prostate cancer treatment

Ended Awarded Last action

Contract number
36C26124N0090
Awardee
Awarding agency
Obligated
$1,819,183

Award facts

Contract value 100% obligated
$1,819,182.92 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Millburn, NJ 07041, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00003 · Deobligate and closeout FY24 funds, PO# 640C49015, fluvicto - lutetium -$292,161
Close Out P00002 · Deobligate excess funds and close -$810,264
Exercise an Option P00001 · Exercise clin option $973,869
Original award $1,947,739

About this award

Veterans Integrated Service Network 21 issued a delivery order to Advanced Accelerator Applications USA Inc. on October 1, 2023, for Pluvicto (lutetium Lu 177 vipivotide tetraxetan) prostate cancer treatment, with a ceiling value of $1,819,182.92.

The order is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) on a firm fixed-price basis. Place of performance is Millburn, NJ. The ultimate completion date is September 30, 2024. The award deobligates and closes out FY24 funds against the prior purchase order 640C49015 for Fluvicto–lutetium supply. Advanced Accelerator Applications USA Inc. is a large, foreign-owned subsidiary of Novartis specializing in radiopharmaceuticals and nuclear medicine products; no subcontractors are identified.

Quick answers

Who was awarded contract 36C26124N0090?

36C26124N0090 was awarded to Advanced Accelerator Applications USA Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on October 1, 2023.

How much is contract 36C26124N0090 worth?

The government has obligated $1,819,183 on 36C26124N0090.

Is contract 36C26124N0090 an order under another contract?

Yes. 36C26124N0090 is a delivery order under 36F79719D0169, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26124N0090 competed?

The extent of competition for 36C26124N0090 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award